-
1
-
-
84891418810
-
Deaths: Leading causes for 2010
-
Heron M. Deaths: leading causes for 2010. Natl Vital Stat Rep. 2013; 62: 1-96.
-
(2013)
Natl Vital Stat Rep.
, vol.62
, pp. 1-96
-
-
Heron, M.1
-
2
-
-
84920703518
-
Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013
-
Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015; 385: 117-171.
-
(2015)
Lancet
, vol.385
, pp. 117-171
-
-
-
3
-
-
84867135202
-
Incidence and cost of pneumonia in medicare beneficiaries
-
Thomas CP, Ryan M, Chapman JD, et al. Incidence and cost of pneumonia in medicare beneficiaries. Chest. 2012; 142: 973-981.
-
(2012)
Chest
, vol.142
, pp. 973-981
-
-
Thomas, C.P.1
Ryan, M.2
Chapman, J.D.3
-
4
-
-
84855204394
-
Clinical and economic burden of community-acquired pneumonia among adults in Europe
-
Welte T, Torres A, Nathwani D. Clinical and economic burden of community-acquired pneumonia among adults in Europe. Thorax. 2012; 67: 71-79.
-
(2012)
Thorax
, vol.67
, pp. 71-79
-
-
Welte, T.1
Torres, A.2
Nathwani, D.3
-
5
-
-
84859406106
-
Association of diagnostic coding with trends in hospitalizations and mortality of patients with pneumonia, 2003-2009
-
Lindenauer PK, Lagu T, Shieh MS, et al. Association of diagnostic coding with trends in hospitalizations and mortality of patients with pneumonia, 2003-2009. JAMA. 2012; 307: 1405-1413.
-
(2012)
JAMA
, vol.307
, pp. 1405-1413
-
-
Lindenauer, P.K.1
Lagu, T.2
Shieh, M.S.3
-
6
-
-
0021677926
-
Tolerance study of ceftriaxone compared with amoxicillin in patients with pneumonia
-
Baumgartner JD, Glauser MP. Tolerance study of ceftriaxone compared with amoxicillin in patients with pneumonia. Am J Med. 1984; 77: 54-58.
-
(1984)
Am J Med.
, vol.77
, pp. 54-58
-
-
Baumgartner, J.D.1
Glauser, M.P.2
-
7
-
-
77649203752
-
Higher vs lower positive end-expiratory pressure in patients with acute lung injury and acute respiratory distress syndrome: Systematic review and meta-analysis
-
Briel M, Meade M, Mercat A, et al. Higher vs lower positive end-expiratory pressure in patients with acute lung injury and acute respiratory distress syndrome: systematic review and meta-analysis. JAMA. 2010; 303: 865-873.
-
(2010)
JAMA
, vol.303
, pp. 865-873
-
-
Briel, M.1
Meade, M.2
Mercat, A.3
-
8
-
-
0035829842
-
Early goal-directed therapy in the treatment of severe sepsis and septic shock
-
Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001; 345: 1368-1377.
-
(2001)
N Engl J Med.
, vol.345
, pp. 1368-1377
-
-
Rivers, E.1
Nguyen, B.2
Havstad, S.3
-
9
-
-
70350498834
-
Pathogenesis, treatment, and prevention of pneumococcal pneumonia
-
van der Poll T, Opal SM. Pathogenesis, treatment, and prevention of pneumococcal pneumonia. Lancet. 2009; 374: 1543-1556.
-
(2009)
Lancet
, vol.374
, pp. 1543-1556
-
-
Van Der-Poll, T.1
Opal, S.M.2
-
10
-
-
34548022149
-
Understanding the inflammatory cytokine response in pneumonia and sepsis: Results of the genetic and inflammatory markers of sepsis (GenIMS) study
-
Kellum JA, Kong L, Fink MP, et al. Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study. Arch Intern Med. 2007; 167: 1655-1663.
-
(2007)
Arch Intern Med.
, vol.167
, pp. 1655-1663
-
-
Kellum, J.A.1
Kong, L.2
Fink, M.P.3
-
11
-
-
33748416499
-
Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412
-
Suntharalingam G, Perry MR, Ward S, et al. Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412. N Engl J Med. 2006; 355: 1018-1028.
-
(2006)
N Engl J Med.
, vol.355
, pp. 1018-1028
-
-
Suntharalingam, G.1
Perry, M.R.2
Ward, S.3
-
12
-
-
4644252704
-
The acute respiratory distress syndrome
-
Piantadosi CA, Schwartz DA. The acute respiratory distress syndrome. Ann Intern Med. 2004; 141: 460-470.
-
(2004)
Ann Intern Med.
, vol.141
, pp. 460-470
-
-
Piantadosi, C.A.1
Schwartz, D.A.2
-
13
-
-
0036852860
-
Incidence, clinical course, and outcome in 217 patients with acute respiratory distress syndrome
-
Estenssoro E, Dubin A, Laffaire E, et al. Incidence, clinical course, and outcome in 217 patients with acute respiratory distress syndrome. Crit Care Med. 2002; 30: 2450-2456.
-
(2002)
Crit Care Med.
, vol.30
, pp. 2450-2456
-
-
Estenssoro, E.1
Dubin, A.2
Laffaire, E.3
-
15
-
-
33750102027
-
Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV infection
-
Ewald H, Raatz H, Boscacci R, et al. Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV infection. Cochrane Database Syst Rev. 2015; 4: CD006150.
-
(2015)
Cochrane Database Syst Rev.
, vol.4
, pp. CD006150
-
-
Ewald, H.1
Raatz, H.2
Boscacci, R.3
-
17
-
-
78651044171
-
The effect of hydrocortisone upon the course of pneumococcal pneumonia treated with penicillin
-
Wagner HN, Jr., Bennett IL, Jr., Lasagna L, et al. The effect of hydrocortisone upon the course of pneumococcal pneumonia treated with penicillin. Bull Johns Hopkins Hosp. 1956; 98:197-215.
-
(1956)
Bull Johns Hopkins Hosp.
, vol.98
, pp. 197-215
-
-
Wagner, H.N.1
Bennett, I.L.2
Lasagna, L.3
-
18
-
-
0015499839
-
Ampicillin dosage and use of prednisolone in treatment of pneumonia: Co-operative controlled trial
-
McHardy VU, Schonell ME. Ampicillin dosage and use of prednisolone in treatment of pneumonia: co-operative controlled trial. Br Med J. 1972; 4: 569-573.
-
(1972)
Br Med J.
, vol.4
, pp. 569-573
-
-
McHardy, V.U.1
Schonell, M.E.2
-
19
-
-
0027257361
-
Hydrocortisone and tumor necrosis factor in severe community-acquired pneumonia. A randomized controlled study
-
Marik P, Kraus P, Sribante J, et al. Hydrocortisone and tumor necrosis factor in severe community-acquired pneumonia. A randomized controlled study. Chest. 1993; 104: 389-392.
-
(1993)
Chest
, vol.104
, pp. 389-392
-
-
Marik, P.1
Kraus, P.2
Sribante, J.3
-
20
-
-
19944430688
-
Hydrocortisone infusion for severe community-acquired pneumonia: A preliminary randomized study
-
Confalonieri M, Urbino R, Potena A, et al. Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study. Am J Respir Crit Care Med. 2005; 171: 242-248.
-
(2005)
Am J Respir Crit Care Med.
, vol.171
, pp. 242-248
-
-
Confalonieri, M.1
Urbino, R.2
Potena, A.3
-
21
-
-
84941782074
-
Effects of low-dose hydrocortisone in ICU patients with severe community-acquired pneumonia
-
M.H.
-
El-Ghamrawy AHS, M.H.; Esmat, A.A. Effects of low-dose hydrocortisone in ICU patients with severe community-acquired pneumonia. Egyptian Journal of Chest Disease and Tuberculosis. 2006; 55: 91-99.
-
(2006)
Egyptian Journal of Chest Disease and Tuberculosis
, vol.55
, pp. 91-99
-
-
El-Ghamrawy, A.H.S.1
Esmat, A.A.2
-
22
-
-
34548569037
-
Efficacy of corticosteroids in the treatment of community-acquired pneumonia requiring hospitalization
-
Mikami K, Suzuki M, Kitagawa H, et al. Efficacy of corticosteroids in the treatment of community-acquired pneumonia requiring hospitalization. Lung. 2007; 185: 249-255.
-
(2007)
Lung
, vol.185
, pp. 249-255
-
-
Mikami, K.1
Suzuki, M.2
Kitagawa, H.3
-
23
-
-
77952307234
-
Efficacy of corticosteroids in community-acquired pneumonia: A randomized double-blinded clinical trial
-
Snijders D, Daniels JM, de Graaff CS, et al. Efficacy of corticosteroids in community-acquired pneumonia: a randomized double-blinded clinical trial. Am J Respir Crit Care Med. 2010; 181: 975-82.
-
(2010)
Am J Respir Crit Care Med.
, vol.181
, pp. 975-982
-
-
Snijders, D.1
Daniels, J.M.2
De Graaff, C.S.3
-
24
-
-
79952561515
-
Effect of corticosteroids on the clinical course of community-acquired pneumonia: A randomized controlled trial
-
Fernandez-Serrano S, Dorca J, Garcia-Vidal C, et al. Effect of corticosteroids on the clinical course of community-acquired pneumonia: a randomized controlled trial. Crit Care. 2011; 15: R96.
-
(2011)
Crit Care
, vol.15
, pp. R96
-
-
Fernandez-Serrano, S.1
Dorca, J.2
Garcia-Vidal, C.3
-
25
-
-
79958771376
-
Dexamethasone and length of hospital stay in patients with community-acquired pneumonia: A randomised, double-blind, placebo-controlled trial
-
Meijvis SC, Hardeman H, Remmelts HH, et al. Dexamethasone and length of hospital stay in patients with community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial. Lancet. 2011; 377: 2023-2030.
-
(2011)
Lancet
, vol.377
, pp. 2023-2030
-
-
Meijvis, S.C.1
Hardeman, H.2
Remmelts, H.H.3
-
26
-
-
84868148522
-
E.E. Corticosteroids and ICU course of community acquired pneumonia in egyptian settings
-
Sabry NAO, E.E. Corticosteroids and ICU course of community acquired pneumonia in egyptian settings. Pharmacology & Pharmacy. 2011; 2: 73-81.
-
(2011)
Pharmacology & Pharmacy
, vol.2
, pp. 73-81
-
-
Sabry, N.A.O.1
-
28
-
-
84928423838
-
Adjunct prednisone therapy for patients with community-acquired pneumonia: A multicentre, double-blind, randomised, placebo-controlled trial
-
Blum CA, Nigro N, Briel M, et al. Adjunct prednisone therapy for patients with community-acquired pneumonia: a multicentre, double-blind, randomised, placebo-controlled trial. Lancet. 2015; 385: 1511-1518.
-
(2015)
Lancet
, vol.385
, pp. 1511-1518
-
-
Blum, C.A.1
Nigro, N.2
Briel, M.3
-
29
-
-
84923125114
-
Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: A randomized clinical trial
-
Torres A, Sibila O, Ferrer M, et al. Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a randomized clinical trial. JAMA. 2015; 313: 677-686.
-
(2015)
JAMA
, vol.313
, pp. 677-686
-
-
Torres, A.1
Sibila, O.2
Ferrer, M.3
-
30
-
-
27644487803
-
Randomized trials stopped early for benefit: A systematic review
-
Montori VM, Devereaux PJ, Adhikari NK, et al. Randomized trials stopped early for benefit: a systematic review. JAMA. 2005; 294: 2203-2209.
-
(2005)
JAMA
, vol.294
, pp. 2203-2209
-
-
Montori, V.M.1
Devereaux, P.J.2
Adhikari, N.K.3
-
31
-
-
77949879943
-
Stopping randomized trials early for benefit and estimation of treatment effects: Systematic review and meta-regression analysis
-
Bassler D, Briel M, Montori VM, et al. Stopping randomized trials early for benefit and estimation of treatment effects: systematic review and meta-regression analysis. JAMA. 2010; 303: 1180-1187.
-
(2010)
JAMA
, vol.303
, pp. 1180-1187
-
-
Bassler, D.1
Briel, M.2
Montori, V.M.3
-
32
-
-
79953768331
-
Impact of systemic corticosteroids on the clinical course and outcomes of patients with severe community-acquired pneumonia: A cohort study
-
Salluh JI, Soares M, Coelho LM, et al. Impact of systemic corticosteroids on the clinical course and outcomes of patients with severe community-acquired pneumonia: a cohort study. J Crit Care. 2011; 26: 193-200.
-
(2011)
J Crit Care
, vol.26
, pp. 193-200
-
-
Salluh, J.I.1
Soares, M.2
Coelho, L.M.3
-
33
-
-
84883191744
-
Impact and indication of early systemic corticosteroids for very severe community-acquired pneumonia
-
Ugajin M, Yamaki K, Hirasawa N, et al. Impact and indication of early systemic corticosteroids for very severe community-acquired pneumonia. Int J Gen Med. 2013; 6: 693-701.
-
(2013)
Int J Gen Med.
, vol.6
, pp. 693-701
-
-
Ugajin, M.1
Yamaki, K.2
Hirasawa, N.3
-
34
-
-
80052838876
-
Analysis of systemic corticosteroid usage and survival in patients requiring mechanical ventilation for severe community-acquired pneumonia
-
Chon GR, Lim CM, Koh Y, Hong SB. Analysis of systemic corticosteroid usage and survival in patients requiring mechanical ventilation for severe community-acquired pneumonia. J Infect Chemother. 2011; 17: 449-455.
-
(2011)
J Infect Chemother.
, vol.17
, pp. 449-455
-
-
Chon, G.R.1
Lim, C.M.2
Koh, Y.3
Hong, S.B.4
-
35
-
-
84877920907
-
Is prolonged low-dose glucocorticoid treatment beneficial in community-acquired pneumonia?
-
Confalonieri M, Annane D, Antonaglia C, et al. Is prolonged low-dose glucocorticoid treatment beneficial in community-acquired pneumonia? Curr Infect Dis Rep. 2013; 15: 158-166.
-
(2013)
Curr Infect Dis Rep.
, vol.15
, pp. 158-166
-
-
Confalonieri, M.1
Annane, D.2
Antonaglia, C.3
-
36
-
-
84898725594
-
Corticosteroid therapy for severe community-acquired pneumonia: A meta-analysis
-
Cheng M, Pan ZY, Yang J, Gao YD. Corticosteroid therapy for severe community-acquired pneumonia: a meta-analysis. Respir Care. 2014; 59: 557-563.
-
(2014)
Respir Care
, vol.59
, pp. 557-563
-
-
Cheng, M.1
Pan, Z.Y.2
Yang, J.3
Gao, Y.D.4
-
37
-
-
80053255664
-
Corticosteroid therapy for acute lung injury, acute respiratory distress syndrome, and severe pneumonia: A meta-analysis of randomized controlled trials
-
Lamontagne F, Briel M, Guyatt GH, et al. Corticosteroid therapy for acute lung injury, acute respiratory distress syndrome, and severe pneumonia: a meta-analysis of randomized controlled trials. J Crit Care. 2010; 25: 420-435.
-
(2010)
J Crit Care
, vol.25
, pp. 420-435
-
-
Lamontagne, F.1
Briel, M.2
Guyatt, G.H.3
-
39
-
-
84929942592
-
Corticosteroid therapy for severe community-acquired pneumonia: A meta-analysis
-
Gusmao-Flores D. Corticosteroid therapy for severe community-acquired pneumonia: a meta-analysis. Respir Care. 2014; 59: e118.
-
(2014)
Respir Care
, vol.59
, pp. e118
-
-
Gusmao-Flores, D.1
-
40
-
-
84868087224
-
Corticosteroids in the treatment of community-acquired pneumonia in adults: A meta-analysis
-
Nie W, Zhang Y, Cheng J, Xiu Q. Corticosteroids in the treatment of community-acquired pneumonia in adults: a meta-analysis. PLoS One. 2012; 7: e47926.
-
(2012)
PLoS One
, vol.7
, pp. e47926
-
-
Nie, W.1
Zhang, Y.2
Cheng, J.3
Xiu, Q.4
-
41
-
-
84873419809
-
Adjuvant steroid therapy in community-acquired pneumonia: A systematic review and meta-analysis
-
Shafiq M, Mansoor MS, Khan AA, et al. Adjuvant steroid therapy in community-acquired pneumonia: a systematic review and meta-analysis. J Hosp Med. 2013; 8: 68-75.
-
(2013)
J Hosp Med.
, vol.8
, pp. 68-75
-
-
Shafiq, M.1
Mansoor, M.S.2
Khan, A.A.3
-
42
-
-
0031794530
-
Severe community-acquired pneumonia. Assessment of severity criteria
-
Ewig S, Ruiz M, Mensa J, et al. Severe community-acquired pneumonia. Assessment of severity criteria. Am J Respir Crit Care Med. 1998; 158: 1102-1108.
-
(1998)
Am J Respir Crit Care Med.
, vol.158
, pp. 1102-1108
-
-
Ewig, S.1
Ruiz, M.2
Mensa, J.3
-
43
-
-
84928414786
-
Corticosteroids and pneumonia: Time to change practice
-
Annane D. Corticosteroids and pneumonia: time to change practice. Lancet. 2015; 385: 1484-1485.
-
(2015)
Lancet
, vol.385
, pp. 1484-1485
-
-
Annane, D.1
-
44
-
-
84895515747
-
Resource use by patients hospitalized with community-acquired pneumonia in Europe: Analysis of the REACH study
-
Ostermann H, Garau J, Medina J, et al. Resource use by patients hospitalized with community-acquired pneumonia in Europe: analysis of the REACH study. BMC Pulm Med. 2014; 14: 36.
-
(2014)
BMC Pulm Med.
, vol.14
, pp. 36
-
-
Ostermann, H.1
Garau, J.2
Medina, J.3
-
45
-
-
67149138523
-
Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease
-
Walters JA, Tan DJ, White CJ, et al. Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2014; 9: CD001288.
-
(2014)
Cochrane Database Syst Rev.
, vol.9
, pp. CD001288
-
-
Walters, J.A.1
Tan, D.J.2
White, C.J.3
-
46
-
-
84941789631
-
-
Accessed May 18, 2015
-
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. 2015. Available at: http://www.goldcopd.org/uploads/users/files/GOLD-Report- 2015-Apr2.pdf. Accessed May 18, 2015.
-
(2015)
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
-
-
-
47
-
-
33749240921
-
Psychiatric adverse effects of corticosteroids
-
Warrington TP, Bostwick JM. Psychiatric adverse effects of corticosteroids. Mayo Clin Proc. 2006; 81: 1361-1367.
-
(2006)
Mayo Clin Proc.
, vol.81
, pp. 1361-1367
-
-
Warrington, T.P.1
Bostwick, J.M.2
|